Galectin Therapeutics
GALT
GALT
62 hedge funds and large institutions have $13M invested in Galectin Therapeutics in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
98% less call options, than puts
Call options by funds: $15K | Put options by funds: $679K
Holders
62
Holding in Top 10
–
Calls
$15K
Puts
$679K
Top Buyers
| 1 | +$261K | |
| 2 | +$257K | |
| 3 | +$243K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$138K |
| 5 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
+$136K |
Top Sellers
| 1 | -$3.4M | |
| 2 | -$480K | |
| 3 | -$145K | |
| 4 |
BCA
Benchmark Capital Advisors
New York
|
-$116K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$110K |